EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes

Fumihiko Kakizaki, Hiroyuki Miyoshi, Takehito Yamamoto iD, Tomonori Morimoto iD, Hiroyuki Matsubara, Shoichi Kitano iD, Tadayoshi Yamaura, Hisatsugu Maekawa, J B Brown, Tosiya Shun Sato, Kazutaka Obama, Yoshiharu Sakai und 2 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Fumihiko Kakizaki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Personalized Cancer Therapy Laboratory, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplastic Stem Cells, Transcriptome. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on mRNA Expression Profiles of 57 Patient‐Derived Colorectal Cancer Stem‐Like Cell ( CRC ‐ SC ) Lines Compared With Normal Colonic Epithelial Stem‐Like Cells ( NCE ‐ SCs ), we Identified Five CRC Subtypes. The First Subtype of CRC ‐ SCs Showed Markedly Increased Expression of MUC12 , PIGR , PLA2G2A , SLC4A4 , and ZG16 , Which Were Barely Detectable in the Other Subtypes. Importantly, Their Expression Correlated With Favorable Outcomes in Both the Discovery Cohort and Independent Two Test Cohorts From Public Databases. The Remaining Four Subtypes Showed High Expression of DEFA6 , BST2 , MAGEA6 , or IGF2 Compared With NCE ‐ SCs . Although the Expression of Each Gene Individually Influenced Patient Outcomes, Additional Co‐Expressed Genes Within Each Subtype Were Also Associated With Prognosis. Furthermore, Integrating the Five Subtype‐Specific Signatures Produced a Practical Prognostic Indicator, Designated as the General Colorectal Cancer Signature ( GCS ), and Provided Individualized Predictive Signatures for Each Patient. The Clinical Significance of GCS Was Further Validated in a Novel Orthotopic Xenograft Mouse Model, Which Recapitulated Patient Outcomes: CRC ‐ SCs With Low GCS Scores Developed Distinct Liver and Lung Metastases, Whereas Those With High Scores Did Not. Apparent Associations Were Observed Between Activating RAS / RAF Mutations and BST2 Expression, and Between the Absence of SMAD4 Mutation and IGF2 Expression, but These Had no Significant Impact on Patient Survival, Suggesting That Driver Gene Mutations May Not Directly Influence GCS . Collectively, Our Findings Provide a Comprehensive Overview of Clinically Relevant Molecular Subtypes of CRC ‐ SCs , Representing the Current Landscape of CRC Molecular Expression Subtypes. They Also Enable Rapid, Low‐Cost Outcome Prediction and Suggest Potential Targets for Therapeutics Development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeoplastic Stem CellsTranscriptomeHumansPrognosisAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticGene Expression ProfilingFemaleBiomarkers, TumorMale

Stichwörter der Autor:innen

colorectal neoplasmsmetastasisneoplastic stem cellsprognosistranscriptome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Personalized Cancer Therapy Laboratory, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Medical Research Institute Kitano Hospital, Osaka, Japan.
  • Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Innovation Research Promotion Center, Institute of Statistical Mathematics, and Data Science and AI, Shiga University, Hikone, Shiga, Japan.

ORCID-Profile: Takehito Yamamoto, Tomonori Morimoto, Shoichi Kitano, Makoto Mark Taketo

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Kakizaki, F., Miyoshi, H., Yamamoto, T., Morimoto, T., Matsubara, H., Kitano, S., Yamaura, T., Maekawa, H., Brown, J. B., Sato, T. S., Obama, K., Sakai, Y., Kawada, K., & Taketo, M. M. (2026). Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes. Cancer Science. https://doi.org/10.1111/cas.70235

Vancouver

Kakizaki F, Miyoshi H, Yamamoto T, Morimoto T, Matsubara H, Kitano S, et al. Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes. Cancer Science. 2026. doi:10.1111/cas.70235

BibTeX
@article{Kakizaki2026,
  author = {Kakizaki, Fumihiko and Miyoshi, Hiroyuki and Yamamoto, Takehito and Morimoto, Tomonori and Matsubara, Hiroyuki and Kitano, Shoichi and Yamaura, Tadayoshi and Maekawa, Hisatsugu and Brown, J B and Sato, Tosiya Shun and Obama, Kazutaka and Sakai, Yoshiharu and Kawada, Kenji and Taketo, Makoto Mark},
  title = {Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70235}
}
Kostenlos starten →